Benjamin Pinsky

About

Joel Cabrita is the Susan Ford Dorsey Director of the Center for African Studies at Stanford University. His research interests include Eswatini, history, postcolonial theory, religion, media, and marginality in Africa. His work focuses on understanding the social and political dynamics within African contexts, particularly in relation to postcolonial developments and cultural expressions.

Research topics

• Medicine
• Virology
• Biology
• Internal medicine
• Computer Science
• Pathology
• Immunology
• Genetics
• Microbiology
• Computational biology

Selected publications

• Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens

  JAMA · 2020 · 819 citations

  This study describes the prevalence of SARS-CoV-2 co-infection with noncoronavirus respiratory pathogens in a sample of symptomatic patients undergoing PCR testing in March 2020.

  DOI

• Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

  Science Immunology · 2020 · 506 citations

  SARS-CoV-2-specific antibodies, particularly those preventing viral spike receptor binding domain (RBD) interaction with host angiotensin-converting enzyme 2 (ACE2) receptor, can neutralize the virus. It is, however, unknown which features of the serological response may affect clinical outcomes of COVID-19 patients. We analyzed 983 longitudinal plasma samples from 79 hospitalized COVID-19 patients and 175 SARS-CoV-2-infected outpatients and asymptomatic individuals. Within this cohort, 25 patie…

  DOI

• Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination

  Cell · 2022 · 487 citations

  During the SARS-CoV-2 pandemic, novel and traditional vaccine strategies have been deployed globally. We investigated whether antibodies stimulated by mRNA vaccination (BNT162b2), including third-dose boosting, differ from those generated by infection or adenoviral (ChAdOx1-S and Gam-COVID-Vac) or inactivated viral (BBIBP-CorV) vaccines. We analyzed human lymph nodes after infection or mRNA vaccination for correlates of serological differences. Antibody breadth against viral variants is lower af…

  DOI

• Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection

  Med · 2022 · 426 citations

  DOI

• Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19

  mBio · 2020 · 397 citations

  As we enter the second quarter of the COVID-19 pandemic, with testing for severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2) increasingly available (though still limited and/or slow in some areas), we are faced with new questions and challenges regarding this novel virus. When to test? Whom to test? What to test? How often to test? And, what to do with test results? Since SARS–CoV-2 is a new virus, there is little evidence to fall back on for test utilization and diagnostic stewardship…

  DOI

Recent grants

• NIH Grant R21AI111195

  NIH · $462k · 2017

Frequent coauthors

• Malaya K. Sahoo

  Stanford University

  270 shared

• ChunHong Huang

  Stanford University

  139 shared

• Catherine A. Hogan

  123 shared

• Quynh‐Thu Le

  Stanford University

  110 shared

• Jesse J. Waggoner

  Emory University

  92 shared

• Niaz Banaei

  Stanford University

  87 shared

• James L. Zehnder

  Stanford University

  83 shared

• K.C. Allen Chan

  Chinese University of Hong Kong

  69 shared

Labs

• Center for African Studies Advisory BoardPI

Education

• M.D.

  University of Washington School of Medicine

Similar researchers at Stanford University

• Marcel Fafchampsh-75
• Eran Bendavidh-53